Flagship Harbor Advisors’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$263K	Buy	1,050 +50	+5%	+$12.4K	0.01%	633
2025 Q4	$275K	Sell	1,000 -91	-8%	-$24.9K	0.01%	586
2025 Q3	$286K	Buy	1,091 +39	+4%	+$9.48K	0.01%	646
2025 Q2	$230K	Buy	1,052 +26	+3%	+$5.56K	0.01%	686
2025 Q1	$230K	Buy	+1,026	New	+$283K	0.01%	669
2024 Q4	–	Sell	-795	Closed	-$239K	–	792
2024 Q3	$239K	Sell	795 -95	-11%	-$29.1K	0.01%	634
2024 Q2	$293K	Sell	890 -119	-12%	-$42.1K	0.02%	546
2024 Q1	$399K	Buy	1,009 +327	+48%	+$121K	0.03%	440
2023 Q4	$240K	Sell	682 -13	-2%	-$4.6K	0.02%	547
2023 Q3	$261K	Hold	695	–	–	0.02%	511
2023 Q2	$266K	Sell	695 -1,825	-72%	-$652K	0.02%	506
2023 Q1	$873K	Buy	+2,520	New	+$736K	0.08%	239
2022 Q3	–	Sell	-720	Closed	-$218K	–	626
2022 Q2	$218K	Sell	720 -33	-4%	-$10.7K	0.02%	544
2022 Q1	$309K	Sell	753 -456	-38%	-$179K	0.03%	473
2021 Q4	$567K	Sell	1,209 -4	-0.3%	-$1.72K	0.05%	334
2021 Q3	$436K	Hold	1,213	–	–	0.05%	374
2021 Q2	$436K	Sell	1,213 -10	-0.8%	-$3.3K	0.05%	375
2021 Q1	$345K	Buy	1,223 +163	+15%	+$46.6K	0.04%	439
2020 Q4	$300K	Buy	1,060 +2	+0.2%	+$561	0.04%	429
2020 Q3	$290K	Buy	1,058 +774	+273%	+$205K	0.04%	375
2020 Q2	$64K	Buy	+284	New	+$55.8K	0.01%	783
2018 Q4	–	Sell	-163	Closed	-$20K	–	2121
2018 Q3	$20K	Sell	163 -78	-32%	-$8.75K	﹤0.01%	1122
2018 Q2	$23K	Buy	+241	New	+$22.2K	﹤0.01%	1056